Risk of febrile neutropenia as a function of age and disease stage in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropenia management – results from the NeuCuP analysis
M. Aapro, M. Schwenkglenks, G. Lyman, A. Lopez-Pousa, P. Bacon, S. Lawrinson, G. Von MinckwitzVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70805-x
File:
PDF, 73 KB
english, 2008